Losartan potassium CAS NO.124750-99-8

Active Pharmaceutical Ingredients 2025-03-03

Catalog ID80018025

CAS NO.124750-99-8

Purity 98%

MDL NumberMFCD02092704

Molecular Formula C22H22CIKN6OK

Molecular Weight 461.01

Category Details
Chemical Properties Molecular formula: C22H22ClKN6O<br> Molecular weight: 461.01
Physical Properties Appearance: White to off-white crystalline powder<br> Solubility: Freely soluble in water, soluble in alcohols, slightly soluble in common organic solvents
Mechanism of Action Selective and competitive antagonist of the angiotensin II receptor (AT1 subtype). Blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to reduced blood pressure.
Therapeutic Uses Hypertension: Used as monotherapy or in combination with other antihypertensive agents.<br> Diabetic Nephropathy: Reduces proteinuria and slows progression of kidney disease.<br> Heart Failure: Used in patients intolerant to ACE inhibitors.
Pharmacokinetics Absorption: Well absorbed orally, with a bioavailability of approximately 33%.<br> Distribution: Volume of distribution: 34 L for losartan, 12 L for the active metabolite E-3174.<br> Metabolism: Metabolized in the liver to the active metabolite E-3174, which is 10 to 40 times more potent.<br> Elimination: Half-life of losartan is 2.1 hours, and E-3174 is 7.4 hours.
Storage Conditions Store at room temperature (68–77°F; 20–25°C), protect from light and moisture.
Safety Information Common Side Effects: Dizziness, nasal congestion, back pain.<br> Serious Side Effects: Hypotension, kidney damage, hyperkalemia, allergic reactions.<br> Pregnancy Warning: Discontinue as soon as pregnancy is detected due to fetal toxicity

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.